Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 1;22(2):371-380.
doi: 10.31557/APJCP.2021.22.2.371.

Transcriptional Biomarkers in Oral Cancer: An Integrative Analysis and the Cancer Genome Atlas Validation

Affiliations

Transcriptional Biomarkers in Oral Cancer: An Integrative Analysis and the Cancer Genome Atlas Validation

Kinjal D Patel et al. Asian Pac J Cancer Prev. .

Abstract

Objective: An impervious mortality rate in oral cancer (OC) to a certain extent explains the exigencies of precise biomarkers. Therefore, the study was intended to identify OC candidate biomarkers using samples of healthy normal tissues (N=335), adjacent normal tissues (N=93) and OC tissues (N=533) from online microarray data.

Methods: Differentially expressed genes (DEGs) were recognised through GeneSpring software (Fold change >4.0 and 'p' value.

Keywords: Biomarkers; expression profiling by array; integrative analysis; oral cancer; the cancer genome atlas.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The Basic Work-Flow Demonstrating the Integrative Analysis Study Design. DEGs, differentially expressed genes; DFS, disease-free survival; FC, fold change; FDR, false discovery rate; GEO, gene expression omnibus; GO, gene ontology; KEGG, kyoto encyclopedia of genes and genomes; OC, oral cancer; OS, overall survival; PCA, principal component analysis; PPI, protein-protein interaction; QC, quality control; RMA, robust multi-array analysis; TCGA, the cancer genome atlas
Figure 2
Figure 2
The Protein-Protein Interaction Network for Differentially Expressed Genes in Each Compared Groups: a. oral cancer tissues vs healthy normal tissues; b, oral cancer tissues vs adjacent normal tissues; and c, adjacent normal tissues vs healthy normal tissues
Figure 3
Figure 3
The Overlapping Differentially Expressed Genes three compared groups. a, up-regulated genes; b, down-regulated genes
Figure 4
Figure 4
Survival Analysis of Selected Makers in the Cancer Genome Atlas Database. (a), overall survival for EIF4A2 (p=0.0364); (b), disease free survival for EIF4A2 (p=0.0107); (c), overall survival for PMEPA1 (p=0.0337); (d), disease free survival for CTNNA1 (p=0.0232).

Similar articles

Cited by

References

    1. Ademuyiwa FO, Miller A, O’Connor T, et al. The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort. Breast Cancer Res Treat. 2011;126:797–802. - PubMed
    1. AlHossiny M, Luo L, Frazier WR, et al. Ly6E/K Signaling to TGFβ promotes breast cancer progression, immune escape, and drug resistance. Cancer Res. 2016;76:3376–86. - PMC - PubMed
    1. Ambatipudi S, Gerstung M, Gowda R, et al. Genomic profiling of advanced-stage oral cancers reveals chromosome 11q alterations as markers of poor clinical outcome. PLoS One. 2011;6:e17250. - PMC - PubMed
    1. Aran D, Camarda R, Odegaard J, et al. Comprehensive analysis of normal adjacent to tumor transcriptomes. Nat Commun. 2017;8:1077. - PMC - PubMed
    1. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. - PubMed

Substances